To me its pretty simple–if BIEL can’t market and sell its product, they need to sell the company. The shareholders deserve some respect, and the public deserves the opportunity to use this technology.

If the new company can’t or won’t market this either, the situation would essentially be the same as it is now, but at least the attempt would have been made, and the shareholders would have gotten paid.

It’s been almost a year since BIEL got two FDA approvals and I still can’t go to a store and buy a Sportspatch. This is an epic fail.